Business Description
Avadel Pharmaceuticals PLC
NAICS : 325414
SIC : 2834
ISIN : US05337M1045
Share Class Description:
AVDL: ADRDescription
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.26 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -37 | |||||
| 3-Year EPS without NRI Growth Rate | -37 | |||||
| 3-Year FCF Growth Rate | -4.9 | |||||
| 3-Year Book Growth Rate | 24.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.4 | |||||
| 9-Day RSI | 15.51 | |||||
| 14-Day RSI | 21.96 | |||||
| 6-1 Month Momentum % | 46.07 | |||||
| 12-1 Month Momentum % | 167.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.32 | |||||
| Quick Ratio | 3.3 | |||||
| Cash Ratio | 3.12 | |||||
| Days Inventory | 14589.86 | |||||
| Days Sales Outstanding | 433.07 | |||||
| Days Payable | 80089.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.8 | |||||
| Shareholder Yield % | -33.66 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.59 | |||||
| Operating Margin % | -7893.32 | |||||
| Net Margin % | -9546.26 | |||||
| ROE % | -1048.41 | |||||
| ROA % | -91.76 | |||||
| ROIC % | -170.37 | |||||
| ROC (Joel Greenblatt) % | -1009.23 | |||||
| ROCE % | -129.78 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 524.74 | |||||
| PB Ratio | 6.21 | |||||
| Price-to-Tangible-Book | 7.04 | |||||
| EV-to-EBIT | -6.04 | |||||
| EV-to-EBITDA | -6.14 | |||||
| EV-to-Revenue | 527.61 | |||||
| EV-to-Forward-Revenue | 5.33 | |||||
| EV-to-FCF | -9.26 | |||||
| Price-to-Net-Current-Asset-Value | 7.81 | |||||
| Price-to-Net-Cash | 8.63 | |||||
| Earnings Yield (Greenblatt) % | -16.56 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AVDL
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avadel Pharmaceuticals PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.496 | ||
| EPS (TTM) ($) | -2.08 | ||
| Beta | 2.11 | ||
| Volatility % | 79.02 | ||
| 14-Day RSI | 21.96 | ||
| 14-Day ATR ($) | 0.580036 | ||
| 20-Day SMA ($) | 11.7485 | ||
| 12-1 Month Momentum % | 167.07 | ||
| 52-Week Range ($) | 4.85 - 16.85 | ||
| Shares Outstanding (Mil) | 89.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avadel Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avadel Pharmaceuticals PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avadel Pharmaceuticals PLC Frequently Asked Questions
What is Avadel Pharmaceuticals PLC(AVDL)'s stock price today?
The current price of AVDL is $9.92. The 52 week high of AVDL is $16.85 and 52 week low is $4.85.
When is next earnings date of Avadel Pharmaceuticals PLC(AVDL)?
The next earnings date of Avadel Pharmaceuticals PLC(AVDL) is 2023-11-09 Est..
Does Avadel Pharmaceuticals PLC(AVDL) pay dividends? If so, how much?
Avadel Pharmaceuticals PLC(AVDL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers